BioNTech decides to develop the treatment of malaria by mRNA technology-based vaccine. BioNTech is the company that developed the COVID-19 vaccine with Pfizer. It will clinically test the mRNA technology-based malaria vaccine by the end of 2022. This company is exploring vaccine production in Africa to enhance the manufacturing capacity and to ease global access to the vaccine.
